Compare Medtronic PLC (MDT) vs OneSpan Inc (OSPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs OneSpan Inc — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while OneSpan Inc trades at $18.22 (market cap $662.97M). The key difference: Medtronic PLC is far larger — about 169.3× OneSpan Inc's market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and OneSpan Inc for 18 Days on average.
| MDT | OSPN | |
|---|---|---|
Market Cap | $112.24B | $662.97M |
Volume | 105,663,236 | 616,882 |
Sector | Health | Technology |
52-Week High | $105.35 | $18.42 |
52-Week Low | $73.75 | $10.15 |
Typical Hold Time | 63 Days | 18 Days |
Enterprise Value | $131.58B | $632.05M |
Dividend Yield | 3.28% | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong fundamental performance including three consecutive quarterly earnings beats and a 49-year dividend growth streak. The stock shows bearish technical signals but maintains solid profitability with 13.93% net margins and positive cash flow trends. Recent regulatory approvals for medical devices and raised guidance signal operational momentum despite mixed technical indicators.
Outlook remains positive with analyst consensus at $97.80 (11% upside) and no sell ratings, though technical weakness and increasing debt-to-asset ratios pose near-term risks. The 3.2% dividend yield provides income support while revenue growth acceleration to $37.5B projected for 2026 offers growth potential.
OneSpan (OSPN) trades at $18.01, up 1.75% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with a 27.76% net margin and consistent earnings beats, though 2026 projections show slight margin compression. Recent product innovation with DigipassONE and institutional interest from Deutsche Bank highlight growth potential amid competitive pressures.
Outlook remains positive with 67% analyst buy ratings and attractive valuation at 10.16 P/E, but investors face risks from subscription transition execution and market volatility. The stock's current technical positioning near key resistance at $19 requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →
